Expert consensus on management of metabolic disease in Chinese liver transplant recipients

doi:10.3748/wjg.v26.i27.3851

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 26, Issue 27

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7992)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

457

WORD

192

HTML

4135

Figures (1-1)

336

Tables (1-4)

288

Sum=5408

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

967

Download

1617

Sum=2584

Jul 21, 2020 (publication date) through Oct 3, 2024

Times Cited of This Article

Times Cited (11)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Guidelines

World J Gastroenterol. Jul 21, 2020; 26(27): 3851-3864
Published online Jul 21, 2020. doi: 10.3748/wjg.v26.i27.3851

Table 1 Adverse effects of immunosuppressive agents on post-liver transplant metabolic disease

Metabolic disease	Glucocorticoids	CNIs (TAC)	CNIs (CsA)	mTORi	MPA	Antibody drugs (ATG/basiliximab)
Diabetes mellitus	+++	++	+	+	-	-
Hypertension	++	++	++	-	-	-
Dyslipidemia	++	+	++	+++	-	-
Obesity	+	+	+	-	-	-
Hyperuricemia	-	++	++	-	-	-

CNI: Calcineurin inhibitor; TAC: Tacrolimus; CsA: Cyclosporine A; mTORi: Mammalian target of rapamycin; MPA: Mycophenolic acids.

Citation: Shen T, Zhuang L, Sun XD, Qi XS, Wang ZH, Li RD, Chang WX, Yang JY, Yang Y, Zheng SS, Xu X. Expert consensus on management of metabolic disease in Chinese liver transplant recipients. World J Gastroenterol 2020; 26(27): 3851-3864
URL: https://www.wjgnet.com/1007-9327/full/v26/i27/3851.htm
DOI: https://dx.doi.org/10.3748/wjg.v26.i27.3851